ArticleCanadian journal of pain = Revue canadienne de la douleur2022

Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report.

Joshua MacAusland-Berg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.